Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

The world has turned upside-down since Donald Trump began his second term as President on 20th January, and things previously thought unthinkable have been happening at an alarming rate.